Vitaspring Biomedical Co Stock Volatility

VitaSpring Biomedical Pink Sheet Volatility Analysis

VitaSpring Biomedical Projected Return Density Against Market

Given the investment horizon of 90 days VitaSpring Biomedical has a beta that is very close to zero . This entails the returns on DOW JONES INDUSTRIAL and VitaSpring Biomedical do not appear to be highly-sensitive. It does not look like VitaSpring Biomedical's alpha can have any bearing on the current valuation. VitaSpring Biomedical's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how vitaspring pink sheet's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a VitaSpring Biomedical Price Volatility?

Several factors can influence a pink sheet's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

VitaSpring Biomedical Pink Sheet Return Volatility

VitaSpring Biomedical historical daily return volatility represents how much of VitaSpring Biomedical pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7121% volatility on return distribution over the 90 days horizon.

Volatility is a rate at which the price of VitaSpring Biomedical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of VitaSpring Biomedical may increase or decrease. In other words, similar to VitaSpring's beta indicator, it measures the risk of VitaSpring Biomedical and helps estimate the fluctuations that may happen in a short period of time. So if prices of VitaSpring Biomedical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

VitaSpring Biomedical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on VitaSpring Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much VitaSpring Biomedical's price varies over time.

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against VitaSpring Biomedical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. VitaSpring Biomedical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, VitaSpring Biomedical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to VitaSpring Biomedical Co.

When running VitaSpring Biomedical's price analysis, check to measure VitaSpring Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VitaSpring Biomedical is operating at the current time. Most of VitaSpring Biomedical's value examination focuses on studying past and present price action to predict the probability of VitaSpring Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VitaSpring Biomedical's price. Additionally, you may evaluate how the addition of VitaSpring Biomedical to your portfolios can decrease your overall portfolio volatility.